Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sarepta Therapeutics (GB:0L35)
LSE:0L35
Sarepta Therapeutics (0L35) Ownership - Who Owns Sarepta Therapeutics?
1 Followers
Sarepta Therapeutics (0L35) Ownership Overview
47.65% Insiders
36.61% Mutual Funds
14.08% Other Institutional Investors
1.66% Public Companies and
Individual Investors
The ownership structure of Sarepta Therapeutics (GB:0L35) stock is a mix of institutional, retail and individual investors. Approximately 50.69% of the company’s stock is owned by Institutional Investors, 47.65% is owned by Insiders and 1.66% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 11, 2024 | Hans Lennart Rudolf Wigzell Director | Sold | $1848795 |
| Mar 11, 2024 | Kathryn Jean Boor Director | Sold | $93550 |
| Mar 06, 2024 | Stephen Mayo Director | Sold | $385480 |
| Mar 05, 2024 | Sold | $200019 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $1698325 | |
| Dec 31, 2023 | Sold | $2544594 | |
| Dec 31, 2023 | Bought | $43574113 | |
| Dec 31, 2023 | Sold | $116687339 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,095,871 | Institution | 8.63% | 959,304,042 | |
| 7,695,475 | Institution | 8.20% | 911,859,919 | |
| 3,291,648 | Institution | 3.51% | 390,037,246 | |
| 3,181,688 | Insider | 3.39% | 377,007,756 | |
| 2,368,526 | Institution | 2.52% | 280,653,751 | |
| 2,283,656 | Institution | 2.43% | 270,597,250 | |
| 2,071,465 | Institution | 2.21% | 245,454,102 | |
| 1,580,418 | Institution | 1.68% | 187,268,470 | |
| 1,540,079 | Institution | 1.64% | 182,488,581 | |
| 1,210,073 | Institution | 1.29% | 143,385,180 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,695,475 | Institution | 8.20% | 911,859,919 | |
| 3,291,648 | Institution | 3.51% | 390,037,246 | |
| 2,283,656 | Institution | 2.43% | 270,597,250 | |
| 2,071,465 | Institution | 2.21% | 245,454,102 | |
| 1,580,418 | Institution | 1.68% | 187,268,470 | |
| 1,540,079 | Institution | 1.64% | 182,488,581 | |
| 999,416 | Institution | 1.06% | 118,423,800 | |
| 940,900 | Institution | 1.00% | 111,490,064 | |
| 897,900 | Institution | 0.96% | 106,394,865 | |
| 776,314 | Institution | 0.83% | 91,987,775 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Sarepta Therapeutics (GB:0L35)?
According to the latest TipRanks data, approximately 14.08% of the company's stock is held by institutional investors, 47.65% is held by insiders, and 1.66% is held by retail investors.
What percentage of Sarepta Therapeutics (GB:0L35) stock is held by institutional investors?
According to the latest TipRanks data, approximately 14.08% of Sarepta Therapeutics (GB:0L35) stock is held by institutional investors.
What percentage of Sarepta Therapeutics (GB:0L35) stock is held by retail investors?
According to the latest TipRanks data, approximately 1.66% of Sarepta Therapeutics (GB:0L35) stock is held by retail investors.
Who owns the most shares of Sarepta Therapeutics (GB:0L35)?
Vanguard owns the most shares of Sarepta Therapeutics (GB:0L35).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.